Organogenesis Holdings Inc.

NASDAQ:ORGO

3.07 (USD) • At close October 17, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

202320222021202020192018201720162015
Operating Activities:
Net Income 4.94515.53294.90217.949-40.454-64.831-2.094-0.209-24.261
Depreciation & Amortization 23.44918.03116.6767.4689.4316.9785.6287.3197.685
Deferred Income Tax 2.0121.98-31.9760.1120.1110.186000
Stock Based Compensation 8.9966.5523.8641.6610.9361.0750.9190.4730.459
Change In Working Capital -18.073-34.082-39.288-26.164-9.667-22.4011.507-0.354-2.887
Accounts Receivables 5.539-8.77-30.232-18.825-4.691-7.11-7.01-6.5561.406
Inventory -8.179-9.41-9.302-6.7-11.063-5-1.49-5.367-8.198
Accounts Payables -0.1083.263.847-0.6354.7-0.06000
Other Working Capital -15.325-19.162-3.601-0.0041.387-10.2311.5070.0083.905
Other Non Cash Items 9.58816.84617.85.7756.11518.254-0.156-303.88.811
Operating Cash Flow 30.91724.85961.9786.801-33.528-60.739-0.587-0.562-10.193
Investing Activities:
Investments In Property Plant And Equipment -24.364-33.898-31.22-21.145-6.234-1.857-2.426-1.361-0.51
Acquisitions Net 000-5.8200.001-11.7900
Purchases Of Investments 000000000
Sales Maturities Of Investments 000000000
Other Investing Activites 0002.132-0.250.001-0.658-3100.121
Investing Cash Flow -24.364-33.898-31.22-24.833-6.234-1.856-14.874-310-0.389
Financing Activities:
Debt Repayment -5.173-3.013-65.188-25.911-18.851-22.69-0.1-0.3-8.95
Common Stock Issued 02.072.19864.72950.3492-0.428303.80
Common Stock Repurchased 0-0.648-0.7370-6.7620000
Dividends Paid 000000000
Other Financing Activities -0.3320.0464.1523.65111.89712.332-0.3287.9761.836
Financing Cash Flow -5.505-2.199-1.03642.46878.72781.642-0.328311.47610.786
Other Information:
Effect Of Forex Changes On Cash 000000000
Net Change In Cash 1.048-11.23829.72224.43638.96519.047-0.9140.9140.204
Cash At End Of Period 104.338103.29114.52884.80660.3721.4050.1261.041.199